Affiliation:
1. Associate Professor, Department of Pathology Institute of Postgraduate Medical Education and Research, Kolkata.
2. Associate Professor, Department of Nephrology, Institute of Postgraduate Medical Education and Research, Kolkata
3. Director, Institute of Postgraduate Medical Education and Research, Health University, Kolkata, India
Abstract
AIMS: Rapidly progressive glomerulonephritis (RPGN) presents with rapidly deteriorating renal function (> 50% loss
of glomerular ltration rate /GFR within 3 months) associated with nephritic urinary sediments and crescents in biopsy.
Crescentric IgA Nephropathy, Anti-GBM (Glomerular basement membrane) disease and combined IgA Nephropathy with Anti-GBM disease
are three uncommon reasons of RPGN. We have compared clinicopathological. Immunouorescence (DIF) and renal outcome of three groups.
Setting and designs: Prospective, cross-sectional, single centre study.
METHODS AND MATERIALS :Ultrasonography guided core biopsies obtained, one stained with hematoxylin-eosin, periodic acid-Schiff,
Masson's trichrome, and silver methenamine stain another one with immunouorescence conjugated IgG, IgM, IgA, C3, C1q, kappa and lambda
stain. Demographic, clinicopathological and therapeutic parameters with survival data were collected.
STATISTICAL ANALYSIS USED: Done using software (GraphPad PRISM 6).
RESULTS: We have included 9 cases of crescentric IgA Nephropathies, 6 cases of AntiGBM diseases and 2 cases of combined IgA
Nephropathy and AntiGBM diseases. Signicant difference seen in the incidences of hypertension, hemoptysis, serum creatinine, anti GBM
antibody, total number of crescents and mesangial hypercellularity, fragmentation of GBM etc. IgG, IgA and kappa positivity in DIF show
signicant difference. Survival analysis and mortality versus dialysis dependence and complete and partial remission versus no remission
showed no difference between these three groups.
CONCLUSIONS: Proper and early clinicopathological diagnosis is important since all are of poor renal outcome. Further renal outcome of the
combined disease is same as that of individual ones.
Reference38 articles.
1. Berti A, Cornec-Le Gall E, Cornec D, Casal Moura M, Matteson EL, Crowson CS, Ravindran A, Sethi S, Fervenza FC, Specks U. Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort. Nephrol. Dial. Transplant. 2019 Sep 01;34(9):1508-1517.
2. Austin HA 3d, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proli¬ferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25(4):689-95.
3. Sasatomi Y, Kiyoshi Y, Takabeyashi S. A clinical and pathological study on the characteristics and factors influencing the prognosis of crescentic glomerulonephritis using a cluster analysis. Pathol Int 1999; 49(9):781-5.
4. Jennette JC, Nickeleit V. Anti-glomerular basement membrane glomerulonephritis and Goodpasture syndrome. In:Jennette JC, Silva FG, Olson JL et al. (eds). Heptinstall’s Pathology of the Kidney. 7th edn. Philadelphia, PA: Wolters Kluwer, 2015, pp. 657–684
5. Cui Z, Zhao M-H. Advances in human antiglomerular basement membrane disese. Nat Rev Nephrol 2011; 7: 697–705